Pulmonary Hypertension News

September 20, 2021September 20, 2021

Study: Health-related Quality of Life in PAH Stays Stable Over Time

Pulmonary Hypertension News

Health-related quality of life does not change substantially over time among people with pulmonary arterial hypertension (PAH) — though PAH patients who experience more substantial disease progression tend to report ... Read more

September 17, 2021September 17, 2021

Actelion, Owkin Partner on Machine Learning to Improve Clinical Trials

Pulmonary Hypertension News

A joint effort between the startup Owkin and Actelion Pharmaceuticals, one of the Janssen companies, will seek to develop machine learning techniques that could improve how clinical trials are designed, and ... Read more

September 16, 2021September 16, 2021

New Institute Aims to Leave No Rare Disease Patient Behind

Pulmonary Hypertension News

A newly launched non-profit institute is seeking to advance research, and the development of new therapies, for people with rare diseases — a patient community with some of the largest ... Read more

September 15, 2021September 15, 2021

Low-alcohol Red Wine Reduced PAH Symptoms in Rats

Pulmonary Hypertension News

Regularly consuming low-alcohol red wine reduced signs of pulmonary arterial hypertension (PAH) in a rat model of the disease, a study shows. “The results of this study suggest that chronic ... Read more

September 13, 2021September 13, 2021

Bayer Doles Out $1M of Its PHAB Awards to 7 Research Projects

COVID-19 News, Pulmonary Hypertension News

As part of the company’s Pulmonary Hypertension Accelerated Bayer (PHAB) Awards, Bayer is giving a total of $1 million to seven research projects related to pulmonary hypertension. The awards are ... Read more

September 10, 2021September 10, 2021

Apabetalone Fares Well in Early Clinical Trial

COVID-19 News, Pulmonary Hypertension News

Apabetalone (RVX-208), Resverlogix‘s experimental treatment for pulmonary arterial hypertension (PAH), was well-tolerated in a small clinical trial, the company announced. The trial met its primary goal of adding apabetalone to ... Read more

September 9, 2021September 9, 2021

Group Focuses on Rare Disease Clinical Trial Participation

Pulmonary Hypertension News

Participation in clinical trials exposes rare disease patients to financial, physical, and emotional pressures, according to the results of a patient focus group series. “Rare disease trial participants are running ... Read more

September 8, 2021September 8, 2021

Using Oxygen Aids Exercise in PH-HFpEF Patients Without Hypoxemia

Pulmonary Hypertension News

Breathing oxygen-enriched air can significantly improve exercise performance in people with  pulmonary hypertension (PH) linked to heart failure with preserved ejection fraction (HFpEF), including those who might not use supplemental ... Read more

September 3, 2021September 3, 2021

Breast Milk Linked to Better Heart Health in Premature Babies

Pulmonary Hypertension News

For premature babies who are at high risk of pulmonary hypertension (PH) and other cardiovascular complications, consuming human breast milk in the first year of life is associated with better heart ... Read more

September 2, 2021September 2, 2021

‘Running for Rare’: NORD a Charity Partner of 2021 NYC Marathon

Pulmonary Hypertension News

The National Organization for Rare Disorders, known as NORD, was named an official charity partner of the 2021 TCS New York City Marathon, which will be held Nov. 7 both ... Read more

September 1, 2021September 1, 2021

Uptravi Found to Reduce Risk, by Half, of PAH Disease Progression

Pulmonary Hypertension News

Early treatment with Janssen’s Uptravi (selexipag) can halve the risk of disease progression for people with pulmonary arterial hypertension (PAH), a new analysis found. The results showed patients treated with ... Read more

August 30, 2021August 30, 2021

Low Oxygen Increases Chloride Levels in PASMCs in Animal Study

Pulmonary Hypertension News

Higher levels of chloride in pulmonary artery smooth muscle cells (PASMCs) may contribute to the development of pulmonary hypertension (PH) after exposure to low oxygen (hypoxia), a study in a ... Read more

August 27, 2021August 27, 2021

FDA Grants Orphan Drug Status to Inhaled Imatinib Formulation

Pulmonary Hypertension News

AER-901, an inhaled formulation of imatinib being developed as a treatment for pulmonary arterial hypertension (PAH), has been granted orphan drug designation by the U.S. Food and Drug Administration (FDA). ... Read more

August 25, 2021August 25, 2021

Home-based Exercise Can Be Viable Alternative in PAH

COVID-19 News, Pulmonary Hypertension News

A six-month at-home rehabilitation program can help improve respiratory muscle strength and physical endurance, while promoting better quality of life, in people with pulmonary arterial hypertension (PAH) That finding from ... Read more

August 24, 2021August 24, 2021

‘Not Alone in the Dark’: New Guide for, by Caregivers of Children With Rare Diseases

Pulmonary Hypertension News

The National Alliance for Caregiving, in partnership with Global Genes, has issued a free guidebook, available online, that offers resources and support for caregivers of children with rare diseases. “The ... Read more